Unclaimed brand
Learn about TAGRISSO® (osimertinib), a targeted therapy for patients with certain types of EGFRm non-small cell lung cancer (NSCLC). For US HCPs.
Liking this brand profile? Share this page
Hex Code
Color name
RGB
HSL
CMYK
#D6964A
Di Serria
214, 150, 74
33, 63, 56
0, 30, 65, 16
#000000
Black
0, 0, 0
0, 0, 0
0, 0, 0, 100
#6BBAEF
Jordy Blue
107, 186, 239
204, 80, 68
55, 22, 0, 6
TAGRISSO® is a renowned brand that offers targeted therapy for both resectable and metastatic EGFRm non-small cell lung cancer (NSCLC). With its innovative and effective treatments, TAGRISSO® has become the first-line treatment choice for metastatic EGFRm NSCLC. The brand aims to revolutionize the field of cancer treatment by specifically targeting the driver of the disease.
In terms of efficacy, TAGRISSO® has shown remarkable results in clinical trials. For resectable EGFRm NSCLC, it has been found to reduce the risk of death by 51% compared to placebo. Moreover, in metastatic EGFRm NSCLC, TAGRISSO® has achieved a median overall survival of more than 3 years, surpassing other treatment options.
TAGRISSO® prioritizes patient safety, offering important information about potential adverse reactions and drug dosing. It has been used to treat over 45,000 patients in the United States alone, and its efficacy and safety have been well-documented in various studies.
By constantly pushing the boundaries of medical science, TAGRISSO® continues to provide hope and improve the lives of individuals battling EGFRm NSCLC.
How do I download the TAGRISSO® (osimertinib) HCP logo?
The TAGRISSO® (osimertinib) HCP logo comes in one version: a logo. Download as transparent PNG.
What are TAGRISSO® (osimertinib) HCP's brand colors?
The TAGRISSO® (osimertinib) HCP color palette uses the hex codes #D6964A, #000000 and #6BBAEF.
The TAGRISSO® (osimertinib) HCP name, logos and brand assets are trademarks of TAGRISSO® (osimertinib) HCP and its affiliates. Brandfetch isn't affiliated with or endorsed by TAGRISSO® (osimertinib) HCP. Their use is subject to TAGRISSO® (osimertinib) HCP's brand guidelines.
